ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

In Brief: ACS Considers Expanding Psychosocial Program, Taylor Says; Mendelsohn, Pitot Join NTP Board

March 25, 1983

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975